Some improvements, but risks of DTCA (direct-to-consumer advertising) remain
Answer to the consultation on the "Concept paper on pharmacovigilance implementing measures"
read (292 KB)
Revised proposals on "information" to patients: still an open door to advertising of prescription-only medicines by pharmaceutical companies
read (279 KB)
Page 1 of 1, showing 18 records out of 18 total, starting on record 1, ending on 18
ISDB - International Society of Drug bullettins
Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it
© 2012